Advanced breast cancer: Anti-progressive immunotherapy using a thermostable autologous hemoderivative

Breast Cancer Research and Treatment

Volumn 100, Issue 2, 2006, Pages 149-160

  Lasalvia Prisco, Eduardo ^a,b   Vázquez, Jesús ^b,d   Golomar, Wilson ^b,d   Larrañaga, Joshemaria ^b,d   Garcia Giralt, Emilio ^c   Cucchi, Silvia ^d   Lasalvia Galante, Eduardo ^d  

^a PharmaBlood Inc   (United States)

^b National Institute of Oncology   (Uruguay)

^c Centre De Cancerologie Hartmann   (France)

^d Department of Advanced Medical Treatments ^*  (Uruguay)

Author keywords

Autologous; Breast; Cancer; Hemoderivative; Vaccine

Indexed keywords

AUTOANTIGEN; CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BREAST CANCER; CANCER IMMUNIZATION; CD4+ CD25+ T LYMPHOCYTE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHORESIS; FOLLOW UP; HUMAN; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TUMOR GROWTH;

ADULT; AGED; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOTHERAPY; MIDDLE AGED; PROSPECTIVE STUDIES; T-LYMPHOCYTES, REGULATORY;

EID: 33750305273     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9235-7     Document Type: Article

References (31)

1. Lasalvia E, Cucchi S, DeStefani E et al (1995) Autologous induction of tumoral fibrogenesis. Neoplasia 12(1):5-10
2. Lasalvia E, Cucchi S, Carlevaro T et al (1995) Anti-metastatic effect of a blood fraction from cancer patients. (Meeting abstract). Proceedings 31st Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, USA, Abstract No: 730
3. Lasalvia-Prisco E, Cucchi S, Vázquez J et al (2003) Antitumoral effect of a vaccination procedure with an autologous hemoderivative. Cancer Biol Ther March/April 2(2):155-160
4. Berd D, Mastrangelo MJ, Engstrong P et al (1982) Augmentation of the human immune response by cyclophosphamide. Cancer Res 42:4862-4866
5. Leong SP, Enders-Zohr P, Zhou YM et al (1999) Recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF) and autologous melanoma vaccine mediate tumor regression in patients with metastatic melanoma. J Immunother 22(2):166-174
6. Lasalvia-Prisco E, Garcia-Giralt E, Cucchi S et al (2006) Advanced colon cancer: antiprogressive immunotherapy using an autologous hemoderivative. Med Oncol 23(1):91-104
7. Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655
8. Therasse P, Arbuck SG, Einsenhauer EA et al (2000) New guideline to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Nat Cancer Inst 92:205-216
9. World Medical Association Declaration of Helsinki: Recommendations guiding medical doctors in biomedical research involving human subjects. Adopted by the 18th World Medical Assembly, Helsinki, Finland, 1964 and as revised in Tokyo, 1975, in Venice, 1983, in Hong Kong, 1989. Version with changes of 1997
10. PDQ (Physician Data Query) National Cancer Institute, comprehensive cancer database
11. Garcia-Giralt E, Lasalvia-Prisco E, Cucchi S et al (2005) Breast cancer: role of tumor associated antigens and regulatory cells [CD4+CD25+] as targets of the immune response elicited by an anti-progressive autologous hemoderivative vaccine (Meeting abstract). Proceedings 41st Annual Meeting of the American Society of Clinical Oncology, Orlando, FL, USA, Abstract No. 2589
12. Wan Fai Ng, Dugan Phillip J, Ponchel FE et al (2001). Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells. Blood 98(9):2736-2744
13. Gauthier LR, Granotier C, Soria JC et al (2001) Detection of circulating carcinoma cells by telomerase activity. Br J Cancer 84(5):631-635
14. Langen H, Roeder D, Juranville JF et al (1997) Effect of the protein application mode and the acrylamide concentration on the resolution of protein spots separated by two-dimensional gel electrophoresis. Electrophoresis 18:2085-2090
15. National Cancer Institute, US: Common terminology criteria for adverse events v3.0 (CTCAE)
16. Fountoulakis M, Juranville JF, Jiang L et al (2004) Depletion of the high-abundance plasma proteins. Amino Acids 27:249-259
17. Jones E, Dahm-Vicker M, Simon AK et al (2002) Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice. Cancer Immun. 2:1-12
18. Liyanage UK, Moore TT, Hong-Gu Joo et al (2002) Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169:2756-2761
19. Josic D, Buchacher A, Kannicht C et al (1999) Degradation products of factor VIII which can lead to increased immunogenicity. Vox Sang 77:90-99
20. Robinson WE Jr, Montefiori DC, Mitchell WM (1988) Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet 1:790-794
21. Abeyounis CJ, Milgrom F (1976) A thermostable antigen characteristic for carcinogen-induced rat intestinal tumors. J Immunol 116(1):30-34
22. Lomakin MS, Larin AS, Maiskii IN (1978) Thermostable antigens of malignant tumors and normal tissues of experimental animals [Termostabil'nye antigeny zlokachestvennykh tkanei eksperimental'nykh zhivotnykh]. Biull Eksp Biol Med 85(6):726-728
23. Lomakin MS, Larin AS, Maiskii IN (1980) Thermo-stable tumor-associated antigens in the serum of tumor-bearing animals and in tissue cultures of malignant tumors [Termostabil'nye opukhole-assotsiirovannye antigeny v syvorotke krovi zhivotnykh-opukholenositelei i v kul'ture tkani zlokachestvennykh opukholei]. Biull Eksp Biol Med 89(4):452-454
24. Hampton R, Walker M, Marshall J et al (2002). Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells. Oncogene 21(51):7817-7823
25. Burton RM, Hope NJ, Lubbers (1976) A thermostable antigen associated with ovarian cancer. Am J Obstet Gynecol 125(4):472-477
26. Conry RM, Khazaeli MB, Saleh MN et al (1999) Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal versus subcutaneous administration. Clin Cancer Res 5(9):2330-2337
27. Saetang T, Suttijitpaisal P, Ratanabanangkoon K (1998). Preparations of toxic components from Naja kaouthia venom by selective heat denaturation. J Nat Toxins 7(1):37-44
28. Petrunin DD, Lopukin Iu M, Molodenkov MN et al (1982). Immunochemical identification of thermostable alpha-glycoprotein in blood sera in various immune system diseases. Biull Eksp Biol Med 93(4):66-68
29. Bruster HTH, Kuntz BME, Scheja JW (1988) Autovaccination plus heat-inactivated autologous plasma in AIDS patients. Lancet 4:1284-1285
30. Snegotska O (1965) Autovaccines for the treatment of cancer. Folia Clin Int (Barc Spain) 5(6):303-308
31. Karcher D, Lowenthal A, Stoppie P et al (1984) A serum protein affecting the regulation of the immune system. Neurochem Res 9(10): 1423-1430